Aurinia Pharmaceuticals Inc.

📍 Victoria, Canada🗓 Founded 2013👥 325 employees💰 Last funded Apr 2020
Biotechnology Research🌐 auriniapharma.com
Website LinkedIn
Aurinia is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. In January 2021, the Company introduced the first FDA-approved oral therapy indicated for the treatment of adult patients with active lupus nephritis (LN). Aurinia’s head office is in Victoria, British Columbia; its U.S. commercial hub is in Rockville, Maryland; and the Company focuses development efforts globally. Follow us on Twitter at @AuriniaPharma and on LinkedIn.
4
Total investors
0
Early stage
2
Mid stage
2
Late stage
2013
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Canada
2
United States
2
Investor activity2017–2020 · investors recorded per year
201722019120201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Aurinia Pharmaceuticals Inc.?
Aurinia Pharmaceuticals Inc. has 4 investors on record on gritt.io, 2 mid-stage and 2 late-stage investors.
When did Aurinia Pharmaceuticals Inc. last raise funding?
The most recent investment in Aurinia Pharmaceuticals Inc. recorded on gritt.io was in April 2020.
When was Aurinia Pharmaceuticals Inc. founded?
Aurinia Pharmaceuticals Inc. was founded in 2013.
What industry is Aurinia Pharmaceuticals Inc. in?
Aurinia Pharmaceuticals Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Aurinia Pharmaceuticals Inc. based?
Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.